Logo image of BLEE.PA

BLEECKER (BLEE.PA) Stock Fundamental Analysis

EPA:BLEE - Euronext Paris - Matif - FR0000062150 - Common Stock - Currency: EUR

117  +8 (+7.34%)

Fundamental Rating

2

Overall BLEE gets a fundamental rating of 2 out of 10. We evaluated BLEE against 42 industry peers in the Diversified REITs industry. BLEE has a bad profitability rating. Also its financial health evaluation is rather negative. BLEE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BLEE had negative earnings in the past year.
In the past year BLEE had a positive cash flow from operations.
In multiple years BLEE reported negative net income over the last 5 years.
Each year in the past 5 years BLEE had a positive operating cash flow.
BLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFBLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

The Return On Assets of BLEE (-4.02%) is worse than 88.10% of its industry peers.
BLEE has a worse Return On Equity (-9.23%) than 85.71% of its industry peers.
The Return On Invested Capital of BLEE (1.44%) is worse than 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLEE is below the industry average of 3.60%.
The 3 year average ROIC (0.99%) for BLEE is below the current ROIC(1.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.02%
ROE -9.23%
ROIC 1.44%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
BLEE.PA Yearly ROA, ROE, ROICBLEE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Operating Margin of BLEE (41.14%) is worse than 76.19% of its industry peers.
BLEE's Operating Margin has improved in the last couple of years.
The Gross Margin of BLEE (48.62%) is worse than 73.81% of its industry peers.
BLEE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 41.14%
PM (TTM) N/A
GM 48.62%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
BLEE.PA Yearly Profit, Operating, Gross MarginsBLEE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLEE is destroying value.
BLEE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLEE has about the same amount of shares outstanding.
The debt/assets ratio for BLEE has been reduced compared to a year ago.
BLEE.PA Yearly Shares OutstandingBLEE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
BLEE.PA Yearly Total Debt VS Total AssetsBLEE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

BLEE has an Altman-Z score of 0.90. This is a bad value and indicates that BLEE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BLEE (0.90) is comparable to the rest of the industry.
BLEE has a debt to FCF ratio of 134.87. This is a negative value and a sign of low solvency as BLEE would need 134.87 years to pay back of all of its debts.
BLEE has a worse Debt to FCF ratio (134.87) than 83.33% of its industry peers.
BLEE has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.17, BLEE is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 134.87
Altman-Z 0.9
ROIC/WACC0.34
WACC4.25%
BLEE.PA Yearly LT Debt VS Equity VS FCFBLEE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BLEE has a Current Ratio of 0.93. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
BLEE has a better Current ratio (0.93) than 69.05% of its industry peers.
A Quick Ratio of 0.93 indicates that BLEE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, BLEE is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93
BLEE.PA Yearly Current Assets VS Current LiabilitesBLEE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

BLEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.64%, which is quite impressive.
BLEE shows a decrease in Revenue. In the last year, the revenue decreased by -9.71%.
The Revenue has been growing slightly by 7.33% on average over the past years.
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLEE.PA Yearly Revenue VS EstimatesBLEE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BLEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLEE.PA Price Earnings VS Forward Price EarningsBLEE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLEE indicates a slightly more expensive valuation: BLEE is more expensive than 78.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 57.73
EV/EBITDA N/A
BLEE.PA Per share dataBLEE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BLEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLEECKER

EPA:BLEE (7/31/2025, 7:00:00 PM)

117

+8 (+7.34%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-10 2025-07-10
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap132.21M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.94
P/FCF 57.73
P/OCF 14.21
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-21.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.03
FCFY1.73%
OCF(TTM)8.24
OCFY7.04%
SpS23.7
BVpS227.11
TBVpS224.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE -9.23%
ROCE 1.96%
ROIC 1.44%
ROICexc 1.44%
ROICexgc 1.45%
OM 41.14%
PM (TTM) N/A
GM 48.62%
FCFM 8.55%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
ROICexc(3y)0.99%
ROICexc(5y)0.84%
ROICexgc(3y)1%
ROICexgc(5y)0.84%
ROCE(3y)1.34%
ROCE(5y)1.13%
ROICexcg growth 3Y47.05%
ROICexcg growth 5Y20.23%
ROICexc growth 3Y47.05%
ROICexc growth 5Y20.22%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 134.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 26.2%
Interest Coverage 0.6
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 0.9
F-Score5
WACC4.25%
ROIC/WACC0.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.61%
Cap/Sales(5y)36.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.65%
EBIT growth 3Y45.94%
EBIT growth 5Y17.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1661.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y189.01%
OCF growth 3Y120.64%
OCF growth 5Y3.91%